Scientific deep-dive
Why GLP-1 Drugs Make You Tired — and What Nobody Has Studied
Fatigue runs 11% against 5% on placebo, and rises with dose: 5% to 9% to 11%. That dose-response is the strongest sign the drug is causing it — and almost nothing else has been studied.
Fatigue is in the label, it is roughly twice as common as on placebo, and it gets more common as the dose goes up: 5% on placebo, 9% at 2.4 mg, 11% at 7.2 mg.[1] That dose-response is the most useful thing anyone can tell you about it, because it is the strongest available sign that the drug is causing this rather than the weight loss. Beyond that the honest answer is that almost nobody has studied it, and what follows is reasoning rather than evidence.
What the label counted
In the main adult weight-management trials, covering 2,116 people on semaglutide 2.4 mg, fatigue was reported by 11% against 5% on placebo.[1] It sits in the adverse reactions table alongside nausea and headache — the common, generally self-limiting group — not in any warning section.
A separate table covering the 7.2 mg dose reports the three-way comparison, and this is where it gets interesting: 5% on placebo, 9% at 2.4 mg, 11% at 7.2 mg.[1]
More drug, more tiredness. That pattern is hard to explain by anything other than the drug.
A dose-response relationship is one of the classic arguments for causation. If fatigue were simply a consequence of eating less or losing weight, you would expect it to track weight loss rather than milligrams — and while higher doses do produce more weight loss, the stepwise pattern across three arms is at least suggestive that the drug contributes directly.
What is probably going on
This section is inference. There is no trial that took people with fatigue on a GLP-1, tested an explanation, and reported a result. What there is: several well-established mechanisms that plausibly apply, each of which has its own evidence base elsewhere.
- You are eating substantially less. A large calorie deficit produces tiredness in anyone, by any method. This is the most likely single contributor and the least specific to these drugs.
- Dehydration. Nausea, vomiting and diarrhea all reduce fluid intake and increase losses, and dehydration causes fatigue well before it causes anything worse. It is also the mechanism behind the acute kidney injury the label warns about — see kidneys.
- Under-eating protein specifically. Appetite suppression tends to cut protein first, because protein-rich foods are the ones that feel heaviest. Our protein calculator works a target.
- Losing lean tissue. Roughly a quarter to a third of weight lost is lean mass, which is comparable to what lifestyle programs cost — the lean mass article covers it. Less muscle means the same task takes more of what you have.
- Low blood sugar, if you take something else for it. Fatigue is a hypoglycemia symptom, and the risk lives with insulin and sulfonylureas rather than the GLP-1 — the low blood sugar article sets that out.
What is worth checking rather than assuming
Fatigue is the least specific symptom in medicine, and starting a new drug is exactly when a different cause gets attributed to it. The things worth ruling out are cheap to check and common in this population.
- Thyroid function, which is a routine test and a routine cause.
- Iron and B12, both of which fall when intake drops, and both of which cause exactly this.
- Sleep apnea, which is common in this population and improves with weight loss — see sleep apnea.
- Mood, because low energy and low mood are hard to tell apart from the inside.
None of that is a reason to assume the drug is innocent. It is a reason not to assume it is guilty, which is what happens when a new medicine gets blamed for everything that follows it.
When it is not ordinary tiredness
Frequently Asked Questions
References
- 1.Novo Nordisk Inc. WEGOVY (semaglutide) — US Prescribing Information, Section 6.1 Adverse Reactions: fatigue 11% vs 5% placebo (2.4 mg, N=2,116) and 5%/9%/11% across placebo, 2.4 mg and 7.2 mg (N=1,311) (revised 06/2026) DailyMed (FDA-approved labeling). 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
Related research
GLP-1 Drugs and Low Blood Sugar: Who Is Actually at Risk
A GLP-1 alone is a poor cause of hypoglycemia, because it prompts insulin only when glucose is already high. The risk belongs to what it is taken alongside — and the label says one combination has never been evaluated.
6 min read
GLP-1 Drugs and Suicidal Thoughts: The Warning Came Off in 2026
The Suicidal Behavior and Ideation section was removed from the Wegovy, Zepbound and Saxenda labels in February 2026, after three large studies looked for a signal and none found one.
7 min read
GLP-1 Drugs and Your Kidneys: Protective Over Years, Risky Over Days
Semaglutide cut the risk of kidney failure or kidney death by 24% over a median 3.4 years. The label also warns of acute kidney injury in people dehydrated by vomiting or diarrhea. Both are true.
7 min read
Eating Too Little on a GLP-1: What the Deficiency Data Show
Across 480,825 adults, more than 60% were consuming below estimated requirements, vitamin D deficiency reached 13.6% at a year, and ferritin ran 26–30% below an active comparator.
7 min read
Food Noise: A Patient’s Word That Now Has a Questionnaire
Patients coined the term and the literature followed. It now has a validated five-item instrument — and a 2026 commentary arguing it may not describe anything distinct.
7 min read
GLP-1 Drugs After 65: Strength, Not Just Weight
Grip strength held up in general adult trials even as lean mass fell. In older adults with type 2 diabetes, prolonged use has been linked to the opposite — and no guidelines exist for this age group.
7 min read
Where to get semaglutide (Ozempic / Wegovy) online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Try Ageless
Semaglutide at $119/month, 37% under the register median
From $119/mo
Get started →Trimi Health
Knowing which pharmacy fills the vial — it names VialsRx
From $99/mo
Get started →ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →